J&J to buy Intra-Cellular Therapies for $14.6 billion-March 2024-www.financetom.com

J&J to buy Intra-Cellular Therapies for $14.6 billion

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

J&J to buy Intra-Cellular Therapies for $14.6 billion

Jan 13, 2025 4:05 AM

Jan 13 (Reuters) - Johnson & Johnson ( JNJ ) said on

Monday it would buy drugmaker Intra-Cellular Therapies ( ITCI )

for $14.6 billion, boosting its presence in the market for

neurological disorder treatments.

Previous page： Arc'teryx owner Amer Sports sees sales growth slowing this year Next page： Kontoor Brands' Fiscal Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Arc'teryx owner Amer Sports sees sales growth slowing this year

Feb 25, 2025

LONDON (Reuters) - Sportswear group Amer Sports sees lower sales growth this year after a strong 2024, the company said on Tuesday as it reported fourth-quarter results boosted by its expensive Arc'teryx brand. The Salomon, Arc'teryx and Wilson owner, which listed in New York in February last year, said exchange rates would weigh slightly on its 2025 results. Its revenue...

Kontoor Brands' Fiscal Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued

Feb 25, 2025

07:10 AM EST, 02/25/2025 (MT Newswires) -- Kontoor Brands ( KTB ) reported fiscal Q4 adjusted earnings Tuesday of $1.38 per diluted share, up from $1.28 a year earlier. Analysts polled by FactSet expected $1.34. Net revenue for the quarter ended Dec. 28 was $699.3 million, compared with $669.8 million a year earlier. Analysts surveyed by FactSet expected $698 million....

Dillard's Fiscal Q4 Earnings, Revenue Decline

Feb 25, 2025

07:08 AM EST, 02/25/2025 (MT Newswires) -- Dillard's (DDS) reported fiscal Q4 earnings Tuesday of $13.48 per diluted share, down from $15.44 a year earlier. Analysts polled by FactSet expected $9.82. Revenue for the fiscal quarter ended Feb. 1 was $2.05 billion, down from $2.16 billion a year earlier. Analysts surveyed by FactSet expected $2.00 billion. Shares of the department...

Wynn Resorts Pick of the Week at Smart Insider Following Chair Philip Satre's Stock Purchase

Feb 25, 2025

07:10 AM EST, 02/25/2025 (MT Newswires) -- Wynn Resorts ( WYNN ) was Smart Insider's stock pick of the week after Chair Philip Satre bought $2 million worth of the company's shares at $92.18 apiece on Feb. 18, raising his stake by 67%. This was Satre's second purchase and his first since November 2018, when he purchased $1 million worth...